CMPI Report: Principles for Patient-Centered Prescription Drug Coverage

by is licensed under

Read the Report here.


Principles for Patient-Centered Prescription Drug Coverage

Monday, September 11, 2017  
8:30am – 1:30 pm
National Press Club
Holeman Lounge
529 14th St NW
Washington, DC 20045
 
Panel One:     How PBMs Affect Access and Affordability
 
Moderator:     Peter J. Pitts, President, CMPI
Panelists:         B. Douglas Hoey, CEO, National Community Pharmacists Association
                          Nick Ferreyros, Director of Communications, Community Oncology Alliance
                          Derek Daggett, Senior Business Development Executive, SmithRx

Watch Panel One highlights here.

Keynote Speaker: A. Mark Fendrick, M.D., Director, Center for Value Based Insurance Design, University of Michigan
Introduction by Robert M. Goldberg, CMPI

Watch Dr. A. Mark Fendrick's Keynote Remarks here.

Panel Two:     Principles for PBM Reform and Patient-Centered Prescription Drug Benefits
 
Moderator:   Robert M. Goldberg, PhD, Vice President, CMPI
Panelists:       Shawn Lovering, President, RxTE
                        Susan Pilch, Vice President, Policy & Regulatory Affairs, NCPA
                        A. Mark Fendrick, M.D., University of Michigan
                        Burt Zweigenhaft, Managing Partner, Upstream Partners
 
Watch Panel Two highlights here.
Article Photo Credit: by is licensed under
Sign Up for Our Email Newsletter

RECENT NEWS

The coronavirus could help pharma reset its reputation in Washington

The coronavirus could help pharma reset its reputation in Washington

The coronavirus outbreak could be the pharmaceutical industry’s ticket to saving its reputation in Washington....  Read more

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

Differing philosophies within and outside of government could doom the hub...  Read more

Tort bar’s newest collateral damage: Preterm babies

Tort bar’s newest collateral damage: Preterm babies

Lawsuits allege links between intestinal disease, infant formula and human milk fortifiers...  Read more

DRUGWONKS BLOG